Parv Chapani

Parv Chapani

Auto-generated profile, based on publicly available information

Parv Chapani

BC Cancer Centre for Lymphoid Cancer, Vancouver, CA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2023 in Blood Advances
Verified
Journal Article
Open access
PDF file
JGJames N. Gerson
James N. Gerson
EHElizabeth Handorf
Elizabeth Handorf
DVDiego Villa
Diego Villa
AGAlina S. Gerrie
Alina S. Gerrie
PCParv Chapani
Parv Chapani
SBStefan K Barta
Stefan K Barta
Mantle cell lymphoma (MCL) is a B-cell non-Hodgkin lymphoma; data indicate that blastoid and pleomorphic variants have a poor prognosis. We report characteristics and outcomes of patients with blastoid/pleomorphic variants of MCL. We retrospectively studied adults with newly diagnosed MCL treated from 2000 to 2015. Primary objectives were to describe progression-free survival (PFS) and overall survival (OS). Secondary objectives included characterization of patient characteristics and treatments. Of the 1029 patients with MCL studied, a total of 207 neoplasms were blastoid or pleomorphic variants. Median follow-up period was 82 months (range, 0.1-174 months); median PFS was 38 months (95% confidence interval [CI], 28-66) and OS was 68 months (95% CI, 45-96). Factors associated with PFS were receipt of consolidative autologous hematopoietic transplantation (auto-HCT; hazard ratio [HR], 0.52; 95% CI, 0.31-0.80; P < .05), MCL International Prognostic Index (MIPI) intermediate (HR, 2.3; 95% CI, 1.2-4.3; P < .02) and high (HR, 3.8; 95% CI, 2.0-7.4; P < .01) scores, and complete response to induction (HR, 0.29 (95% CI, 0.17-0.51). Receipt of auto-HCT was not associated with OS (HR, 0.69; 95% CI, 0.41-1.16; P = .16) but was associated with MIPI intermediate (HR, 5.7; 95% CI, 2.5-13.2; P < .01) and high (HR, 10.8; 95% CI, 4.7-24.9; P < .01) scores. We report outcomes in a large cohort of patients with blastoid/pleomorphic variant MCL. For eligible patients, receipt of auto-HCT after induction was associated with improved PFS but not OS. Higher MIPI score and auto-HCT ineligibility were associated with worse survival.

1 June 2022 in Clinical Colorectal Cancer
Verified
Journal Article
Closed access
IYIrene S. Yu
Irene S. Yu
ZAZamzam Al-Hashami
Zamzam Al-Hashami
PCParv Chapani
Parv Chapani
CSCaroline Speers
Caroline Speers
JDJanine M. Davies
Janine M. Davies
JLJonathan M Loree
Jonathan M Loree

21 November 2022 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
VJVictor H. Jimenez-Zepeda
Victor H. Jimenez-Zepeda
DRDonna Reece
Donna Reece
RRRodrigo Rigo
Rodrigo Rigo
PGPriyanka Gogna
Priyanka Gogna
SKShiying Kong
Shiying Kong
DBDevon Boyne
Devon Boyne
Amyloid light chain (AL) amyloidosis is a rare plasma cell disease in which AL protein deposits form throughout the body, with the heart, and kidney being the most commonly affected organs [1,2]. I...